Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | -0.51% |
|
-13.17% | -86.99% |
07-15 | UBS Adjusts Price Target on CareMax to $2.20 From $6.40, Maintains Neutral Rating | MT |
07-11 | CareMax, Inc. Enters into Limited Waiver and Eighth Amendment to Credit Agreement | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.99% | 7.42M | |
+17.86% | 83.02B | |
+0.85% | 26.5B | |
+5.31% | 17.72B | |
-5.74% | 17.49B | |
+6.99% | 16.06B | |
+82.12% | 13.83B | |
+77.49% | 12.84B | |
-26.49% | 12.73B | |
+2.82% | 12.19B |
- Stock Market
- Equities
- CMAX Stock
- News CareMax, Inc.
- Transcript : CareMax, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-13-2022 12